HomeIPSC • NASDAQ
add
Century Therapeutics Inc
Previous close
$0.59
Day range
$0.58 - $0.62
Year range
$0.34 - $1.38
Market cap
52.83M USD
Avg Volume
1.26M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 6.84M | -18.16% |
Net income | -34.42M | -10.24% |
Net profit margin | — | — |
Earnings per share | -0.32 | 13.54% |
EBITDA | -26.23M | 16.70% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 132.75M | -32.99% |
Total assets | 244.72M | -37.03% |
Total liabilities | 68.37M | -64.56% |
Total equity | 176.35M | — |
Shares outstanding | 87.31M | — |
Price to book | 0.29 | — |
Return on assets | -27.73% | — |
Return on capital | -30.41% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -34.42M | -10.24% |
Cash from operations | -25.58M | 9.70% |
Cash from investing | 24.67M | -37.06% |
Cash from financing | 0.00 | -100.00% |
Net change in cash | -913.00K | -108.20% |
Free cash flow | -6.96M | 52.28% |
About
Founded
2018
Headquarters
Website
Employees
140
